Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial-Reference-Cited by-同舟云学术

Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

Published:2021-08-15 Issue:4 Volume:204 Page:462-472
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Nieto Antonio¹^ORCID,Mazón Angel¹^ORCID,Nieto María¹,Calderón Rafael²,Calaforra Susana¹,Selva Blanca¹,Uixera Sonia¹,Palao Maria José²,Brandi Paola³,Conejero Laura⁴^ORCID,Saz-Leal Paula⁴^ORCID,Fernández-Pérez Cristina⁵,Sancho David³^ORCID,Subiza José Luis⁴^ORCID,Casanovas Miguel⁴^ORCID

Affiliation:

1. Unidad de Neumología y Alergia Pediátrica, Instituto de Investigaciones Sanitarias, Hospital Universitario La Fe, Valencia, Spain;

2. Departmento de Pediatría, Manises Hospital, Valencia, Spain;

3. Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain;

4. Inmunotek S.L., Alcalá de Henares, Spain; and

5. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference53 articles.

1. Managing Asthma Exacerbations in the Emergency Department: Summary of the National Asthma Education and Prevention Program Expert Panel Report 3 Guidelines for the Management of Asthma Exacerbations